Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events weighing patient doctor benefit risk preferences psoriasis treatments
… Goyal R, Nagar S, Davis KL, Kaye JA Transcript: Targeted treatments have emerged as frontline therapies for patients …
… cancer screening, which has the potential to improve patient survival. However, cancer screening tests are … caused by the screening process, the likelihood of a high-risk cancer, and the health of the patient. To optimize decisions that take those factors into …
… as a speaker in the DIA 2022 session, Fit-for-Purpose Patient Preference Studies: Emerging Recommendations from IMI … in preference research, including how decision-makers and patient research partners were involved. Alicia Gilsenan, …
Vagus Nerve Stimulation: Cost-Effective Treatment for Drug-Resistant Epilepsy Share on: September 17, 2018 Patients with drug-resistant epilepsy (DRE) utilize more health care resources and face higher costs than patients who can control their condition …
… Jan 11;2018:1-8. Related Services Pharmacoepidemiology and Risk Management Staff Members Susana Perez-Gutthann Alejandro …
… study had a relatively short treatment duration, they had patient data from nearly 10 years. Our team had to address …
Thirteenth Annual FDA Sentinel Initiative Public Workshop Share on: Monday, November 8, 2021, 10am - Tuesday, November 9, 2021, 2pm Workshop registration Image Bradley Layton, PhD , Senior Research Epidemiologist at RTI-HS, will be participating as a …
… product value to support successful reimbursement and patient access. Creating a strategic plan with a Market … payers, regulators, providers, and patients. Who can benefit from early market access planning for rare disease therapies? Companies developing diagnostics or treatments Companies wishing to prepare for acquisition or …
… Many HTA agencies make specific statements about their preferences for health utility measures, but their guidelines … weights are not available, outcomes may be valued using preferences that reflect the general population with … measures. • Recommend using an indirect method with patient-level data collected from clinical trials. Health …
… reviews. Her doctorate investigated the communication of risk information in experiments eliciting preferences for breast cancer screening. Her most recent … Decision Making, PharmacoEconomics, Value in Health, The Patient, the European Journal of Health Economics, the …